CLIMACO JOHN M (Chief Executive Officer) purchased 340.1% of their position (166.67K shares) of CNS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/6/2024ACC: 0001683168-24-000705
DirectorOfficer· Chief Executive Officer
Since Nov 2019
+500K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
500K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+166.67K
Price / share
$0.30
Trade value
$50K
% of position
340.1%
2/1/2024
49.01K→215.68K
Total
Net shares
+166.67K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/1/2024 | P · Purchase | +166.67K | $0.30 | $50K | 340.1% | 49.01K | 215.68K |
| Total | +166.67K | $50K | ||||||
Derivative Transactions2
Series A Warrant to purchase common stock
Direct
Converts to
Common Stock
166.67K shares
Shares
+166.67K
Strike price
0.30
Held after
226.87K
Exercisable
—
2/1/2024
Series B Warrant to purchase common stock
Direct
Converts to
Common Stock
166.67K shares
Shares
+166.67K
Strike price
0.30
Held after
393.53K
Exercisable
—
2/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrant to purchase common stock Direct | Common Stock166.67K shares | 2/1/2024 | A · Award | +166.67K | 0.30 | — | 226.87K |
| Series B Warrant to purchase common stock Direct | Common Stock166.67K shares | 2/1/2024 | A · Award | +166.67K | 0.30 | — | 393.53K |